GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » Cyclically Adjusted Price-to-FCF

RaySearch Laboratories AB (OSTO:RAY B) Cyclically Adjusted Price-to-FCF : 44.78 (As of Jul. 03, 2025)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB Cyclically Adjusted Price-to-FCF?

As of today (2025-07-03), RaySearch Laboratories AB's current share price is kr334.50. RaySearch Laboratories AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was kr7.47. RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF for today is 44.78.

The historical rank and industry rank for RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

OSTO:RAY B' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 7.97   Med: 21.06   Max: 109.03
Current: 43.71

During the past years, RaySearch Laboratories AB's highest Cyclically Adjusted Price-to-FCF was 109.03. The lowest was 7.97. And the median was 21.06.

OSTO:RAY B's Cyclically Adjusted Price-to-FCF is ranked worse than
73.74% of 198 companies
in the Healthcare Providers & Services industry
Industry Median: 19.375 vs OSTO:RAY B: 43.71

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

RaySearch Laboratories AB's adjusted free cash flow per share data for the three months ended in Mar. 2025 was kr2.476. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is kr7.47 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


RaySearch Laboratories AB Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Cyclically Adjusted Price-to-FCF Chart

RaySearch Laboratories AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.34 11.21 11.58 13.40 29.26

RaySearch Laboratories AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.39 19.37 21.21 29.26 30.12

Competitive Comparison of RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF

For the Health Information Services subindustry, RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

RaySearch Laboratories AB Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=334.50/7.47
=44.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RaySearch Laboratories AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, RaySearch Laboratories AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.476/132.8245*132.8245
=2.476

Current CPI (Mar. 2025) = 132.8245.

RaySearch Laboratories AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.567 99.995 0.753
201509 0.380 100.228 0.504
201512 1.190 100.276 1.576
201603 0.640 100.751 0.844
201606 0.434 101.019 0.571
201609 0.297 101.138 0.390
201612 2.160 102.022 2.812
201703 1.154 102.022 1.502
201706 0.753 102.752 0.973
201709 1.040 103.279 1.338
201712 1.365 103.793 1.747
201803 1.634 103.962 2.088
201806 0.429 104.875 0.543
201809 -0.376 105.679 -0.473
201812 3.518 105.912 4.412
201903 1.465 105.886 1.838
201906 3.994 106.742 4.970
201909 1.510 107.214 1.871
201912 2.367 107.766 2.917
202003 1.927 106.563 2.402
202006 3.951 107.498 4.882
202009 2.289 107.635 2.825
202012 1.502 108.296 1.842
202103 3.043 108.360 3.730
202106 1.694 108.928 2.066
202109 1.381 110.338 1.662
202112 0.828 112.486 0.978
202203 3.650 114.825 4.222
202206 0.355 118.384 0.398
202209 -0.966 122.296 -1.049
202212 1.847 126.365 1.941
202303 2.964 127.042 3.099
202306 0.315 129.407 0.323
202309 2.354 130.224 2.401
202312 1.493 131.912 1.503
202403 3.106 132.205 3.121
202406 2.815 132.716 2.817
202409 0.655 132.304 0.658
202412 1.229 132.987 1.227
202503 2.476 132.825 2.476

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


RaySearch Laboratories AB  (OSTO:RAY B) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


RaySearch Laboratories AB Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB Business Description

Traded in Other Exchanges
Address
Eugeniavagen 18C, P.O. Box 3297, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia Pacific, Europe and the rest of the world.

RaySearch Laboratories AB Headlines

No Headlines